A narrative literature review on traditional medicine options for treatment of corona virus disease 2019 (COVID-19)
- 17 June 2020
- journal article
- review article
- Published by Elsevier BV in Complementary Therapies in Clinical Practice
- Vol. 40, 101214
- https://doi.org/10.1016/j.ctcp.2020.101214
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirusAntiviral Research, 2010
- PubChem: a public information system for analyzing bioactivities of small moleculesNucleic Acids Research, 2009
- Medicinal plants of Tamil Nadu (Southern India) are a rich source of antiviral activitiesPharmaceutical Biology, 2009
- TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text miningBMC Complementary and Alternative Medicine, 2008
- In vitro inhibition of coronavirus replications by the traditionally used medicinal herbal extracts, Cimicifuga rhizoma, Meliae cortex, Coptidis rhizoma, and Phellodendron cortexJournal of Clinical Virology, 2008
- Croup Is Associated with the Novel Coronavirus NL63PLoS Medicine, 2005
- Intranasal immunization with inactivated SARS-CoV (SARS-associated coronavirus) induced local and serum antibodies in miceVaccine, 2005
- Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitroAngiogenesis, 2004
- In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquineBiochemical and Biophysical Research Communications, 2004
- Statistical evidence for the usefulness of Chinese medicine in the treatment of SARSPhytotherapy Research, 2004